Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

InteCardia Inc.

This article was originally published in Start Up

Executive Summary

Service Carveouts; Disease Management; Cardiovascular. Although many scientifically proven, easily available regimens can prevent incidences of cardiovascular event, as health care is delivered today, a patient often doesn's get help until he suffersa potentially preventable heart attack. InteCardia hopes to manage cardiovascular disease with programs aimed both at patients who have already suffered cardiac events as well as people at risk of developing disease.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC089719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel